A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are slightly higher this morning, as investors are awaiting earnings reports and retail-sales data. Futures for the Dow Jones Industrial Average surged 13 points to 12,848.00 and S&P 500 index futures rose 1.70 points to 1,350.80. Nasdaq 100 futures jumped 5.50 points to 2,573.25.
A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index rose 0.21%, London's FTSE 100 Index moved up 0.12%, French CAC 40 index rose 0.25% and German DAX 30 index gained 0.38%.
Asian markets ended mostly higher, with Japan's Nikkei Stock Average rising 0.59%, China's Shanghai Composite dropping 0.30% and Australia's S&P/ASX 200 moving down 0.93%. Hong Kong's Hang Seng index gained 0.15% and India's Sensex rose 0.43%.
Broker Recommendation The Benchmark Company upgraded Rackspace Hosting Inc (NYSE: RAX) from “hold” to “buy.” The target price for Rackspace Hosting has been raised from $45 to $60.
Rackspace Hosting shares gained 7.86% to $53.10 in pre-market trading.
Breaking news
- Acacia Research Corporation (NASDAQ: ACTG) announced today that a subsidiary has acquired over 300 patents from Automotive Technologies International relating to numerous automotive safety, navigation and diagnostics technologies. To read the full news, click here.
- Coronado Biosciences Inc (Nasdaq: CNDO) today announced that it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration (FDA) for CNDO-109, a novel biologic that primes natural killer cells without the need for cytokines (IL-2), and is being studied for the treatment of patients with high risk acute myeloid leukemia in first complete remission. To read the full news, click here.
- Arbitron Inc (NYSE: ARB) today announced that its Board of Directors has authorized a program under which the company may repurchase up to $100 million in shares of the company's common stock. To read the full news, click here.
- Sunesis Pharmaceuticals Inc (NASDAQ: SNSS) today announced that the U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance for U.S. Patent Application No. 12/982,785 claiming certain compositions related to Sunesis' lead drug candidate, vosaroxin. To read the full news, click here.
